FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT

LONDON--()-- 

FORM 8.3

Amendment to sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 29 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,768,776

1.37%

190,557

0.15%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

102,935

0.08%

7,066

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,877,811

1.46%

203,723

0.16%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

2

231.9000 USD
Purchase

7

229.2300 USD
Purchase

10

233.9000 USD
Purchase

100

231.0100 USD
Purchase

100

234.9800 USD
Purchase

101

235.1402 USD
Purchase

112

233.5256 USD
Purchase

140

234.4160 USD
Purchase

200

233.6650 USD
Purchase

200

228.5300 USD
Purchase

220

231.1009 USD
Purchase

300

234.7699 USD
Purchase

400

233.8262 USD
Purchase

412

233.7995 USD
Purchase

500

233.1160 USD
Purchase

601

232.9468 USD
Purchase

635

232.9192 USD
Purchase

840

233.5630 USD
Purchase

848

234.5502 USD
Purchase

893

231.6444 USD
Purchase

900

234.0522 USD
Purchase

927

234.5981 USD
Purchase

976

234.6483 USD
Purchase

1,172

234.3778 USD
Purchase

1,362

233.9733 USD
Purchase

1,569

233.2362 USD
Purchase

2,006

234.5297 USD
Purchase

2,046

233.7466 USD
Purchase

2,488

233.3352 USD
Purchase

2,745

232.1078 USD
Purchase

3,160

230.1590 USD
Purchase

4,805

233.3208 USD
Purchase

5,575

233.5422 USD
Purchase

6,751

232.6093 USD
Purchase

7,055

234.5383 USD
Purchase

9,796

234.4936 USD
Purchase

12,223

232.0760 USD
Purchase

13,114

233.7045 USD
Purchase

22,119

233.9087 USD
Purchase

24,368

230.8799 USD
Purchase

28,112

233.9132 USD
Purchase

29,180

234.6000 USD
Sale

5

232.6870 USD
Sale

6

230.2900 USD
Sale

10

233.9000 USD
Sale

17

232.5905 USD
Sale

26

232.1353 USD
Sale

33

232.5663 USD
Sale

35

232.4968 USD
Sale

35

231.2621 USD
Sale

42

229.2300 USD
Sale

43

232.2079 USD
Sale

45

231.8564 USD
Sale

51

232.1955 USD
Sale

52

231.7772 USD
Sale

100

227.3015 USD
Sale

140

234.4160 USD
Sale

155

231.4217 USD
Sale

200

234.1000 USD
Sale

400

232.2175 USD
Sale

449

234.7625 USD
Sale

472

232.9299 USD
Sale

478

234.6573 USD
Sale

500

234.7995 USD
Sale

500

234.9320 USD
Sale

524

234.6673 USD
Sale

563

233.6999 USD
Sale

673

233.8246 USD
Sale

799

232.8010 USD
Sale

804

233.7806 USD
Sale

1,402

228.4826 USD
Sale

1,512

233.7302 USD
Sale

1,817

233.2834 USD
Sale

2,078

231.4307 USD
Sale

2,128

233.7343 USD
Sale

2,616

231.8596 USD
Sale

3,506

233.5534 USD
Sale

5,331

233.0838 USD
Sale

7,013

234.5701 USD
Sale

7,659

233.0929 USD
Sale

12,920

234.4885 USD
Sale

21,609

233.7136 USD
Sale

28,982

234.6000 USD
Sale

43,188

234.7534 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 1 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option

 

 

or derivative

 

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 734485
Time of Receipt (offset from UTC): 20210401T175136+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC